Activity – Aloha Health Network

Recent Activity In Bile Duct Cancer – Extrahepatic Advocate Network

Daniel Christian Patient Advocate joined the group Bile Duct Cancer – Extrahepatic Advocate Network
Aloha Health Network posted an update in the group Bile Duct Cancer – Extrahepatic Advocate Network

For advanced biliary tract cancer patients that also have reduced kidney function (as measured by Creatinine Clearance (CCr) between 50-80ml/min), this study presented January 18, 2019 showed that gemcitabine (GEM) plus S-1 (GS) was better in terms of overall survival, progression free survival, and blood counts than the typical standard of care for 1st line treatment, which is GEM plus cisplatin (GC). Accordingly, ASCO is considering gemcitabine (GEM) plus S-1 (GS) might be recommended for the population with lower renal function in the treatment for advanced biliary tract cancer.

Meeting Library | Meeting Library

https://meetinglibrary.asco.org/record/168565/abstract

2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300
Aloha Health Network joined the group Bile Duct Cancer – Extrahepatic Advocate Network
Ericdrew18 joined the group Bile Duct Cancer – Extrahepatic Advocate Network
Eric Drew joined the group Bile Duct Cancer – Extrahepatic Advocate Network
WeHeal created the group Bile Duct Cancer – Extrahepatic Advocate Network

Recent Activity [RSS]